Base Metals Investing Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Base Metals Investing Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Base Metals Investing Relmada Therapeutics Appoints Distinguished Urologic Oncologist, Max Kates, MD, to the Clinical Advisory Board to Support Development of NDV-01
Nine Mile Metals Announces Certified High-Grade Assay Results up to 15.00% Copper from the Wedge Project, Bathurst, New Brunswick
Apollo Silver Announces $2.5 Million Upsize to Previously Announced Financing to Allow for Insider Participation
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
